High Risk Cardiovascular Disease
1 clinical trials · Condition
◉ Watch High Risk Cardiovascular Disease
| Record | Firm | Date |
|---|---|---|
| Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease (NCT07181109) | Alnylam Pharmaceuticals | 2025-09-22 |
Track High Risk Cardiovascular Disease automatically
Every clearance here is in the API, with alerts when new ones post.